Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Unknown status Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20171
20181
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing InnoCare Pharma Tech Co., Ltd.1
Carisma Therapeutics Inc1
Cell Genesys1
Genta Incorporated1
Merrimack Pharmaceuticals1
MultiVir, Inc.1
SpeciCare1
Vasgene Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell8
Small Cell Lung Carcinoma4
Stomach Neoplasms4
Urinary Bladder Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Bile Duct Neoplasms2
Breast Neoplasms2
Carcinoma, Hepatocellular2
Carcinoma, Renal Cell2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.